MedTrace Logo

Pilot Study of Magnesium Infusions in Pediatric Asthma

NCT01522040 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2017-03-30

No results posted yet for this study

Summary

This is a prospective randomized pilot study that seeks to address the research question: In children with moderate-to-severe asthma, do intravenous magnesium infusions added to standard Pediatric intensive care unit (PICU)-level asthma care significantly decrease time from patient presentation until PICU discharge?

Conditions

Interventions

DRUG

Magnesium Sulfate

Continuous magnesium drip, titrated to effect until patient's symptoms improve

DRUG

Placebo

Simple saline drip, without active drug

Sponsors & Collaborators

  • University of Louisville

    lead OTHER

Principal Investigators

  • Keith Cross, MD · University of Louisville

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01522040 on ClinicalTrials.gov